Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	65147
Country	Italy

Received	2021-02-28 15:50
Peer-Review Started	2021-02-28 15:59
To Make the First Decision
Return for Revision	2021-04-06 04:46
Revised	2021-04-09 16:28
Second Decision	2021-05-25 14:46
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-05-25 15:15
Articles in Press	2021-05-25 15:15
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-06-10 00:23
Typeset the Manuscript	2021-06-18 01:08
Publish the Manuscript Online	2021-06-18 13:06

ISSN	1948-9366 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Opinion Review
Article Title	Borderline resectable pancreatic cancer: Certainties and controversies
Manuscript Source	Invited Manuscript
All Author List	Gennaro Nappo, Greta Donisi and Alessandro Zerbi
Funding Agency and Grant Number
Corresponding Author	Gennaro Nappo, MD, Surgeon, Pancreatic Surgery Unit, Humanitas Clinical and Research Center-IRCCS, Via Manzoni 56, Rozzano 20089, Italy. gennaro.nappo@humanitas.it
Key Words	Borderline resectable pancreatic cancer; Pancreatic cancer; Neoadjuvant treatment; Chemotherapy; Radiotherapy; Pancreatic tumour
Core Tip	The term borderline resectable identifies a tumour with an aggressive biological behaviour, on which a neoadjuvant approach instead of upfront surgery one should be preferred, in order to obtain a radical resection (R0) and to avoid an early recurrence after surgery. The aim of this review is to critically analyze the available literature on this topic.
Publish Date	2021-06-18 13:06
Citation	Nappo G, Donisi G, Zerbi A. Borderline resectable pancreatic cancer: Certainties and controversies. World J Gastrointest Surg 2021; 13(6): 516-528
URL	https://www.wjgnet.com/1948-9366/full/v13/i6/516.htm
DOI	https://dx.doi.org/10.4240/wjgs.v13.i6.516

Full Article (PDF)	WJGS-13-516.pdf
Full Article (Word)	WJGS-13-516.docx
Manuscript File	65147-Review-FilipodiaCL .docx
Answering Reviewers	65147-Answering reviewers.pdf
Audio Core Tip	65147-Audio core tip.mp4
Conflict-of-Interest Disclosure Form	65147-Conflict-of-interest statement.pdf
Copyright License Agreement	65147-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	65147-Language certificate.pdf
Peer-review Report	65147-Peer-review(s).pdf
Scientific Misconduct Check	65147-Scientific misconduct check.pdf
Scientific Editor Work List	65147-Scientific editor work list.pdf